These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21105049)

  • 1. Germline polymorphisms in genes involved in the CD44 signaling pathway are associated with clinical outcome in localized gastric adenocarcinoma.
    Winder T; Ning Y; Yang D; Zhang W; Power DG; Bohanes P; Gerger A; Wilson PM; Lurje G; Tang LH; Shah M; Lenz HJ
    Int J Cancer; 2011 Sep; 129(5):1096-104. PubMed ID: 21105049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Two CD44 Polymorphisms with Clinical Outcomes of Gastric Cancer Patients.
    Bitaraf SM; Mahmoudian RA; Abbaszadegan M; Mohseni Meybodi A; Taghehchian N; Mansouri A; Forghanifard MM; Memar B; Gholamin M
    Asian Pac J Cancer Prev; 2018 May; 19(5):1313-1318. PubMed ID: 29802692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An individual coding polymorphism and the haplotype of the SPARC gene predict gastric cancer recurrence.
    Winder T; Wilson PM; Yang D; Zhang W; Ning Y; Power DG; Bohanes P; Gerger A; Tang LH; Shah M; Lenz HJ
    Pharmacogenomics J; 2013 Aug; 13(4):342-8. PubMed ID: 22491017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variations in angiogenesis pathway genes associated with clinical outcome in localized gastric adenocarcinoma.
    Lurje G; Husain H; Power DG; Yang D; Groshen S; Pohl A; Zhang W; Ning Y; Manegold PC; El-Khoueiry A; Iqbal S; Tang LH; Shah MA; Lenz HJ
    Ann Oncol; 2010 Jan; 21(1):78-86. PubMed ID: 19622587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD44 Genotypes Are Associated with Susceptibility and Tumor Characteristics in Colorectal Cancer Patients.
    Márquez-González RM; Saucedo-Sariñana AM; Barros-Núñez P; Gallegos-Arreola MP; Pineda-Razo TD; Marin-Contreras ME; Flores-Martínez SE; Sánchez-Corona J; Rosales-Reynoso MA
    Tohoku J Exp Med; 2020 Feb; 250(2):109-119. PubMed ID: 32115493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer Stem Cell Gene Variants in CD44 Predict Outcome in Stage II and Stage III Colon Cancer Patients.
    Stotz M; Herzog SA; Pichler M; Smolle M; Riedl J; Rossmann C; Bezan A; Stöger H; Renner W; Berghold A; Gerger A
    Anticancer Res; 2017 Apr; 37(4):2011-2018. PubMed ID: 28373475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD44 single nucleotide polymorphism and isoform switching may predict gastric cancer recurrence.
    Suenaga M; Yamada S; Fuchs BC; Fujii T; Kanda M; Tanaka C; Kobayashi D; Fujiwara M; Tanabe KK; Kodera Y
    J Surg Oncol; 2015 Nov; 112(6):622-8. PubMed ID: 26416034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GRP78 promoter polymorphism rs391957 as potential predictor for clinical outcome in gastric and colorectal cancer patients.
    Winder T; Bohanes P; Zhang W; Yang D; Power DG; Ning Y; Gerger A; Wilson PM; Tang LH; Shah M; Lee AS; Lenz HJ
    Ann Oncol; 2011 Nov; 22(11):2431-2439. PubMed ID: 21382870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased CD44 Expression and MEK Activity Predict Worse Prognosis in Gastric Adenocarcinoma Patients Undergoing Gastrectomy.
    Lin JX; Yoon C; Li P; Yu Q; Qiu SL; Zheng CH; Yoon SS; Huang CM
    J Gastrointest Surg; 2021 May; 25(5):1147-1155. PubMed ID: 32410176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LETM1 is a potential biomarker that predicts poor prognosis in gastric adenocarcinoma.
    Li H; Piao L; Xu D; Xuan Y
    Exp Mol Pathol; 2020 Feb; 112():104333. PubMed ID: 31705880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic association of osteopontin (OPN) and its receptor CD44 genes with susceptibility to Chinese gastric cancer patients.
    Qiu Y; Hu Y; Zhang ZY; Ye L; Xu FH; Schneider ME; Ma XL; Du YX; Zuo XB; Zhou FS; Chen G; Xie XS; Zhang Y; Xia HZ; Wu JF; Du WD
    J Cancer Res Clin Oncol; 2014 Dec; 140(12):2143-56. PubMed ID: 25009318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA repair gene and MTHFR gene polymorphisms as prognostic markers in locally advanced adenocarcinoma of the esophagus or stomach treated with cisplatin and 5-fluorouracil-based neoadjuvant chemotherapy.
    Ott K; Rachakonda PS; Panzram B; Keller G; Lordick F; Becker K; Langer R; Buechler M; Hemminki K; Kumar R
    Ann Surg Oncol; 2011 Sep; 18(9):2688-98. PubMed ID: 21347786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common Variants in Osteopontin and
    Gałecki S; Gdowicz-Kłosok A; Deja R; Masłyk B; Giglok M; Suwiński R; Butkiewicz D
    Cells; 2023 Nov; 12(23):. PubMed ID: 38067149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of Cyclin D1 and CD44 Expression in Gastric Adenocarcinoma.
    Ibrahim HM; AbdElbary AM; Mohamed SY; Elwan A; Abdelhamid MI; Ibrahim A
    J Gastrointest Cancer; 2019 Sep; 50(3):370-379. PubMed ID: 29497929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD44/CD24 expression in recurrent gastric cancer: a retrospective analysis.
    Yong CS; Ou Yang CM; Chou YH; Liao CS; Lee CW; Lee CC
    BMC Gastroenterol; 2012 Jul; 12():95. PubMed ID: 22839505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variations in angiogenesis pathway genes predict tumor recurrence in localized adenocarcinoma of the esophagus.
    Lurje G; Leers JM; Pohl A; Oezcelik A; Zhang W; Ayazi S; Winder T; Ning Y; Yang D; Klipfel NE; Chandrasoma P; Hagen JA; DeMeester SR; DeMeester TR; Lenz HJ
    Ann Surg; 2010 May; 251(5):857-64. PubMed ID: 20101173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Cancer Stem Cell Marker CD44 and Its Polymorphisms in Patients with Chronic Gastritis, Precancerous Gastric Lesion, and Gastric Cancer: A Cross-Sectional Multicenter Study in Thailand.
    Tongtawee T; Wattanawongdon W; Simawaranon T; Kaewpitoon S; Kaengpenkae S; Jintabanditwong N; Tangjanyatham P; Ratchapol W; Kangwantas K; Dechsukhum C; Leeanansaksiri W; Kaewpitoon N; Matrakool L; Panpimanmas S
    Biomed Res Int; 2017; 2017():4384823. PubMed ID: 29445738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fibroblast growth factor receptor-4 Arg388 allele is associated with gastric cancer progression.
    Ye Y; Shi Y; Zhou Y; Du C; Wang C; Zhan H; Zheng B; Cao X; Sun MH; Fu H
    Ann Surg Oncol; 2010 Dec; 17(12):3354-61. PubMed ID: 20844967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
    Guo J; Zu G; Zhou T; Xing J; Wang Z
    Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor receptor 2 gene polymorphisms as predictors for tumor recurrence and overall survival in non-small-cell lung cancer.
    Uzunoglu FG; Kaufmann C; Wikman H; Güngör C; Bohn BA; Nentwich MF; Reeh M; Pantel K; Bockhorn M; Kutup A; Mann O; Izbicki JR; Vashist YK
    Ann Surg Oncol; 2012 Jul; 19(7):2159-68. PubMed ID: 22395975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.